Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR2 | Q92731 | 1/20 | 0.54 |
| ▸ | GSK3B | P49841 | 2/20 | 0.45 |
| ▸ | GSK3A | P49840 | 1/20 | 0.45 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.44 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.44 |
| ▸ | PTPN5 | P54829 | 1/20 | 0.43 |
| ▸ | PPARG | P37231 | 2/20 | 0.42 |
| ▸ | PRKAG1 | P54619 | 3/20 | 0.41 |
| ▸ | PRKAA1 | Q13131 | 3/20 | 0.41 |
| ▸ | PRKAB1 | Q9Y478 | 3/20 | 0.41 |
| ▸ | ACHE | P22303 | 1/20 | 0.41 |
| ▸ | MME | P08473 | 1/20 | 0.41 |
| ▸ | CNR2 | P34972 | 1/20 | 0.41 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.39 |
| ▸ | MYC | P01106 | 1/20 | 0.38 |
| ▸ | WDR5 | P61964 | 1/20 | 0.38 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.38 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.38 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.38 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9846028 | 0.85 | ESR2 (0.56) | ESR2GSK3BGSK3AFFAR1AKR1B1 | |
| SCHEMBL27955134 | 0.82 | ESR2 (0.57) | ESR2GSK3BGSK3AFFAR1AKR1B1 | |
| SCHEMBL5573395 | 0.81 | CYP19A1 (0.51) | ESR2AKR1B1PPARGCNR2GABRG2 | |
| SCHEMBL1713 | 0.79 | ESR2 (0.67) | ESR2GSK3BGSK3AFFAR1AKR1B1 | |
| SCHEMBL28048348 | 0.78 | ESR2 (0.51) | ESR2FFAR1AKR1B1PTPN5MME | |
| SCHEMBL31410710 | 0.78 | ESR2 (0.76) | ESR2GSK3BGSK3AFFAR1AKR1B1 | |
| SCHEMBL7867991 | 0.77 | ESR2 (0.59) | ESR2GSK3BGSK3AFFAR1AKR1B1 | |
| SCHEMBL3169219 | 0.77 | ESR2 (0.59) | ESR2GSK3BGSK3AFFAR1AKR1B1 | |
| SCHEMBL360601 | 0.77 | ESR2 (0.59) | ESR2GSK3BGSK3AFFAR1AKR1B1 | |
| SCHEMBL31124937 | 0.77 | ESR2 (0.59) | ESR2GSK3BGSK3AFFAR1AKR1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0690046-B1 | Method of preparation of biphenyls using palladacyclen as catalyst | CLARIANT GMBH (DE) | 1998-12-23 | — | — | EP | claimed |
| US-5559277-A | Process for preparing biphenyls using palladacycles as catalysts | HOECHST AG (DE) | 1996-09-24 | — | — | US | claimed |
| EP-0690046-A1 | Method of preparation of biphenyls using palladacyclen as catalyst | HOECHST AKTIENGESELLSCHAFT (DE) | 1996-01-03 | — | — | EP | claimed |
| JP-8092132-A | — | — | None | — | — | JP | disclosed |
| US-7282245-B2 | Device with multiple liquid crystal layers | XEROX CORPORATION (US) | 2007-10-16 | — | — | US | disclosed |
| US-7211301-B2 | Liquid crystal compositions including non-dipolar monomer | XEROX CORPORATION (US) | 2007-05-01 | — | — | US | disclosed |
| US-20060088667-A1 | Device with multiple liquid crystal layers | XEROX CORPORATION | 2006-04-27 | — | — | US | disclosed |
| US-6994801-B2 | Compounds of formula (4) to stabilize liquid crystal domains | XEROX CORPORATION (US) | 2006-02-07 | — | — | US | disclosed |
| EP-1439215-B1 | Domain size controlled liquid crystals | XEROX CORP (US) | 2005-12-14 | — | — | EP | disclosed |
| US-6939478-B2 | Compounds of formula (2) to stabilize liquid crystal domains | XEROX CORPORATION (US) | 2005-09-06 | — | — | US | disclosed |
| US-6905633-B2 | Compounds of formula (3) to stabilize liquid crystal domains | XEROX CORPORATION (US) | 2005-06-14 | — | — | US | disclosed |
| US-20040115367-A1 | Compounds of formula (2) to stabilize liquid crystal domains | XEROX CORPORATION | 2004-06-17 | — | — | US | disclosed |
| US-20040113119-A1 | Compounds of formulas (3) and (4) to stabilize liquid crystal domains | XEROX CORPORATION | 2004-06-17 | — | — | US | disclosed |
| US-20040113121-A1 | COMPOUNDS OF FORMULA (1) TO STABILIZE LIQUID CRYSTAL DOMAINS | XEROX CORPORATION | 2004-06-17 | — | — | US | disclosed |
| US-20040115366-A1 | Domain size controlled liquid crystals | XEROX CORPORATION | 2004-06-17 | — | — | US | disclosed |
| US-20040113122-A1 | Liquid crystal compositions including non-dipolar monomer | XEROX CORPORATION | 2004-06-17 | — | — | US | disclosed |
| EP-0690046-B1 | Method of preparation of biphenyls using palladacyclen as catalyst | CLARIANT GMBH (DE) | 1998-12-23 | — | — | EP | disclosed |
| US-5559277-A | Process for preparing biphenyls using palladacycles as catalysts | HOECHST AG (DE) | 1996-09-24 | — | — | US | disclosed |
| JP-H0892132-A | PRODUCTION OF BIPHENYLS USING PALLADACYCLE AS CATALYST | HOECHST AG | 1996-04-09 | — | — | JP | disclosed |
| EP-0690046-A1 | Method of preparation of biphenyls using palladacyclen as catalyst | HOECHST AKTIENGESELLSCHAFT (DE) | 1996-01-03 | — | — | EP | disclosed |